4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Mustang Bio, Inc. (MBIO) operates in the Biotechnology industry and is headquartered in Waltham, United States with about 4 employees. Its market capitalization is roughly $5 million. In the fiscal year ended 2025-12-31, MBIO reported $0M in revenue and ($2M) in net income.
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($13M) | ($51M) | ($76M) | — |
| Net Income | ($2M) | ($16M) | ($52M) | ($78M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($1M) | ($1M) | ($1M) | ($1M) | ($0M) | — |
| Net Income | ($1M) | ($0M) | ($0M) | ($1M) | ($0M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $18M | $9M | $18M | $92M | — |
| Total Liabilities | $8M | $13M | $18M | $46M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MBIO viewer.
About TickerBase · Data methodology & sources